Table 3.
Single-Dose Study | Multiple-Dose Study | ||
---|---|---|---|
Injection Site Adverse Events, n (%) | Deltoid (n = 17) | Gluteal (n = 18) | Total (n = 138) |
Pain | 6 (35.3) | 5 (27.8) | 38 (27.5) |
Rash | 1 (5.9) | 0 | 0 |
Erythema | 0 | 0 | 1 (0.7) |
Induration | 0 | 0 | 1 (0.7) |
Swelling | 0 | 0 | 1 (0.7) |